HMGB1 and Low back pain: The primary outcome measures for this study were determined as the differences in the levels of extracellular HMGB1 release, the quantitative changes in the level of peripheral blood monocytes, and the differences in the mRNA expression levels between the asymptomatic (control) participants and the patients with LBP.